Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior

Chen, B. K., Luna, V. M., Shannon, M. E., Hunsberger, H. C., Mastrodonato, A., Stackmann, M., McGowan, J. C., Rubinstenn, G., & Denny, C. A. (2021). Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior. Biological Psychiatry, 90(7), 458–472. https://doi.org/10.1016/j.biopsych.2021.04.024
Authors:
Briana K. Chen
Victor M. Luna
Margaret E. Shannon
Holly C. Hunsberger
Alessia Mastrodonato
Michelle Stackmann
Josephine C. McGowan
Gilles Rubinstenn
Christine A. Denny
Affiliated Authors:
Briana K. Chen
Victor M. Luna
Margaret E. Shannon
Holly C. Hunsberger
Alessia Mastrodonato
Michelle Stackmann
Josephine C. McGowan
Christine A. Denny
Columbia Affiliation:
Author Keywords:
antidepressant
anxiety
depression
fear
nmdar
prophylactic
elink
Publication Type:
Article
Unique ID:
10.1016/j.biopsych.2021.04.024
PMID:
34274107
DOI:
10.1016/j.biopsych.2021.04.024
Journal:
Biological Psychiatry
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: